Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1994-09-26
1997-06-17
Spiegel, Carol A.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 721, 435 793, 435 794, 435 795, 435 13, 435961, 435962, 435967, 435968, 436531, 436 69, 536 271, 536 281, 536 291, 530386, 5303879, 5303891, 5303893, G01N 3353
Patent
active
056396252
ABSTRACT:
A novel method of detecting antibodies to thrombomodulin in plasma or serum as an indication of an individual's propensity to thrombosis or inflammation is disclosed. A method for identifiying patients at risks of thrombosis or glomerular nephritis by monitoring autoantibodies to truncated soluble thrombomodulin is revealed. A preferred method is an ELISA assay to detect antibodies to thrombomodulin.
REFERENCES:
patent: 4912207 (1990-03-01), Majerus et al.
Branch et al., "The demonstration of lupus anticoagulant by an enzyme-linked immunoadsorbent assay," Clinical Immunology and Immunopathology 39:298-307 (1986).
Brisson, et al., "Antibodies to thrombomodulin induce receptor-mediated endocytosis in human saphenous vein endothelial cells," Thrombosis and Haemostasis 68:737-743 (1992).
Cariou, et al., "Inhibition of Protein C activation by endothelial cells in the presence of lupus anticoagulant," New England J Med 314:1193-1194 (1986).
Cariou, et al., "Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells-inhibition of thrombomodulin-dependent Protein C activation," Thrombosis and Haemostasis 60:54-58 (1988).
Dreyfus, et al., "Treatment of homozygous Protein C deficiency and neonatal purpura fulminans with a purified Protein C concentrate," New England J Med 325:1656-1568 (1991).
Esmon, C. T. "The regulation of natural anticoagulant pathways," Science 235:1348-1352 (1987).
Espevik, et al., "Inhibition of cytokine production by cyclosporin A and transforming growth factor .beta.," J. Exp Med 166:571-576 (1987).
Freyssinet, et al., "An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity-a mechanism for thrombosis," Thrombosis & Haemostasis 55:309-313 (1986).
Freyssinet, et al.,"The effect of phospholipids on the activation of protein C by the human thrombinthrombomodulin complex," Biochem J 238:151-157 (1986).
Gibson, et al., "Autoantibodies to thrombomodulin: development of an enzyme immunoassay and a survey of their frequency in patients with the lupus anticoagulant," Thrombosis and Haemostasis 67:507-509 (1992).
Jackman, et al., "Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control," Proc Natl Acad Sci USA 84:6425-6429 (1987).
Koyama, et al., "Relationship between post-translational glycosylation and anticoagulant function of secretable recombinant mutants of human thrombomodulin," Br J Haematol 78:515-522 (1991).
Love, P.E. and Santoro, S.A. "Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders," Annals of Internal Med 112:682-698 (1990).
McCrae, et al., "Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies," Br J Haematol 79:596;605 (1991).
Oosting, et al., "In vitro studies of antiphospholipid antibodies and it cofactor, .beta..sub.2 -glycoprotein I, show negligible effects on endothelial cell mediated protein C activation,"Thrombosis & Haemostasis 66:666-671 (1991).
Oosting, et al., "Autoantibodies directed against the epidermal growth factor-like domains of thrombomodulin inhibit protein C activation in vitro," Br J Haematol 85:761-768 (1993).
Pengo, et al., "Immunological specificity and mechanism of action of IgG lupus anticoagulants," Blood 70:69-76 (1987).
Potzsch, et al., "Thrombophilia in patients with lupus anticoagulant correlates with impaired anticoagulant activity of activated Protein C but not with decreased activation of Protein C," Blood 80(suppl):267a (1992). abstract No. 1059.
Rezaie, A.R. and Esmon, C. T., "The function of calcium in protein C activation by thrombin and the thrombinthrombomodulin complex can be distinguished by mutational analysis of protein C derivatives," J. Biol. Chem 267:26104-26109 (1992).
Ruiz-Arguelles, et al., "Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin," J Rheumatol 16:381-383 (1989).
Suzuki, et al., "Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein c activation," EMBO J 67:1891-1897 (1987).
Taylor, et al., "Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon," J Clin Invest 79:918-925 (1987).
Thiagarajan, et al., "Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity," J. Clin Invest 66:397-405 (1980).
Triplett, et al., "The relationship between lupus anticoagulants and antibodies to phospholipid," JAMA 259:550-554 (1988).
Triplett, et al., "The laboratory heterogeneity of lupus anticoagulants," Arch Pathol Lab Med 109:946-951 (1985).
Tsakiris, et al., "Lupus anticoagulant-antiphospholipid antibodies and thrombophilia. Relation to protein C -protein S -thrombomodulin," J. Rheumatology 17:785-789 (1990).
Tsiang, et al., "Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity," J Biol Chem 267:6164-6170 (1992).
Zushi, et al., "The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity," J Biol Chem 264:10351-10353 (1989).
Carson Craig W.
Esmon Charles T.
Oklahoma Medical Research Foundation
Spiegel Carol A.
LandOfFree
Method for detecting antibodies to thrombomodulin in patients does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting antibodies to thrombomodulin in patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting antibodies to thrombomodulin in patients will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2157101